Report no. 3/2014

Amendment to a significant contract in the subsidiary company “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodic information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. announces that:
- on 10 January 2014 the Company received annexes to the contracts concluded by the subsidiary company Powiatowe Centrum Zdrowia sp. z o.o. with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) regarding healthcare services such as inpatient care and  outpatient specialist care within the scope of comprehensive specialist outpatient care over a patient with a chronic disease, palliative and hospice care, nursing and care services  in terms of long-term care  for the period 1 January to 31 December 2013,
-medical services  that were rendered under the contract for the provision of healthcare services such as primary healthcare for the period 1 January to  31 December 2013 have been settled.
Healthcare services referred to in the said contracts are provided by the subsidiary company of EMC Instytut Medyczny S.A.- “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary.
The Issuer informed about the contracts concluded by “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary with the Fund Branch concerning rendering services in 2013 in its current reports nos. 11/2013 of 31.01.2013, 37/2013 of 24.04.2013, 70/2013 of 23.07.2013, 86/2013 of 27.08.2013 and 101/2013 of 13.11.2013.
As a result of signing the abovementioned annexes, the value of the contract with highest value has changed and and it currently amounts to PLN 9,235,572.00 ( an increase by PLN 11,024.00).  The total maximum Fund Branch liability towards the subsidiary company currently amounts to PLN 17, 202,096.95 (an increase by PLN 38,781.18) for the period 1 January to 31 December 2013. 
 A criterion for a contract to be considered significant: 
The value of contracts exceeds 10% of the Issuer’s equity capital.